Key Metrics
Recommended pre-submission checks
Powered by 

Topics Covered on Medicines
Medicines Journal Specifications
Indexed in the following public directories
DOAJ
| Overview | |
| Publisher | MDPI AG |
| Language | English |
| Article Processing Charges | CHF 1400 |
| Publication Time | 6 |
| Editorial Review Process | Blind peer review |
| General Details | |
| Language | English |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 6 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in Medicines ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Medicines
Correction: Nasser et al. Potency of Combining Eucalyptus camaldulensis subsp. camaldulensis with Low-Dose Cisplatin in A549 Human Lung Adenocarcinomas and MCF-7 Breast Adenocarcinoma. Medicines 2020, 7, 40
- 14 Jul 2026
- Medicines
FDA-Approved Drugs Containing Amide Functionality in the Last Five Years (2021\u20132025): Pharmaceutical Use, Trends and Synthetic Approaches
- 7 Jul 2026
- Medicines
Beyond Weight Loss: Early Real-World Evidence of Semaglutide in Obesity
- 28 Jun 2026
- Medicines
Cinnamon-Derived Compounds Reduce PD-L1 Expression in UV-Exposed Human Skin Cell Line.
- 20 Jun 2026
- Medicines (Basel, Switzerland)
Narrative Review of Novel Nicotine-Delivery Systems and Emerging Pharmaceuticals for Tobacco Cessation.
- 12 Jun 2026
- Medicines (Basel, Switzerland)
Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia-Guidelines and Recent Developments.
- 30 May 2026
- Medicines (Basel, Switzerland)
Correction: Nasser et al. Potency of Combining Eucalyptus camaldulensis subsp. camaldulensis with Low-Dose Cisplatin in A549 Human Lung Adenocarcinomas and MCF-7 Breast Adenocarcinoma. Medicines 2020, 7, 40
- 14 Jul 2026
- Medicines
FDA-Approved Drugs Containing Amide Functionality in the Last Five Years (2021\u20132025): Pharmaceutical Use, Trends and Synthetic Approaches
- 7 Jul 2026
- Medicines
Beyond Weight Loss: Early Real-World Evidence of Semaglutide in Obesity
- 28 Jun 2026
- Medicines
Cinnamon-Derived Compounds Reduce PD-L1 Expression in UV-Exposed Human Skin Cell Line.
- 20 Jun 2026
- Medicines (Basel, Switzerland)
Narrative Review of Novel Nicotine-Delivery Systems and Emerging Pharmaceuticals for Tobacco Cessation.
- 12 Jun 2026
- Medicines (Basel, Switzerland)
Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia-Guidelines and Recent Developments.
- 30 May 2026
- Medicines (Basel, Switzerland)